You are reading the report for 2026-09-18. The figures are as they stood that day and are not revised. See the current report →
Daily Special Report
Published Sep 19
Where the analysts disagree
The widest disagreement runs from BROS at +47% to LEN at -12%, the outer ends of the target-versus-price gaps. DT sits at +22%, while XENE is +12%, leaving both positive and negative views in the set. These are the most recent targets compared with prices at the time they were set, with grade changes and targets published in the latest analyst feed. Analyst opinion is not a recommendation.
DT has a 2 up / 5 down split, the only one here with that balance. Its +22% gap between target and price is the only one here at +22%, while its disclosed band is —, also the only one here with that band.
split: 2 up, 5 down · BMO Capital, BTIG, Deutsche Bank
Against a $55 – $90 target band, XENE has a +12% gap between target and price, the only one here at +12%. Its split is —, shared with BROS and LEN, and the band is the biggest disclosed band of the 3 here.
targets $55-$90 · Needham, RBC Capital, Robert W. Baird
At BROS, targets run from $59 – $70, while the +47% gap between target and price is the biggest of the 4 here. The split is —, shared with XENE and LEN, and the disclosed band is the second-largest of the 3 here.
targets $59-$70 · Melius Research, Raymond James
For LEN, targets span $63 – $70 and the gap between target and price is -12%, the smallest of the 4 here. The — split matches XENE and BROS, while its disclosed band is the smallest of the 3 here.
targets $63-$70 · BTIG, Barclays, RBC Capital
Grade changes and price targets published in the latest analyst feed. “Target vs price” compares the most recent target with the price at the time it was set. Analyst opinion is not a recommendation.